Showing posts with label guidelines. Show all posts
Showing posts with label guidelines. Show all posts

Tuesday, December 24, 2013

JNC 8: A Nephrology fellow's perspective

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) was released in 2003 and since that time has been an often referenced tool for clinicians seeking to treat hypertension.  From that report we were given useful information such as classification of hypertension along a spectrum of blood pressure ranges , from pre-hypertension to stage 1 and ultimately to stage  2 hypertension.  A goal of <140/90 mmHg should be our target for most of the population, and less than 130/80mmHG for those special populations with increased cardiovascular risk, such as those with diabetes or chronic kidney disease.  Thiazide diuretics were the preferred initial drug for those with uncomplicated stage 1 hypertension.  Multidrug therapy was useful for stage 2 or failure to reach the goal blood pressure.  Simple, straightforward, yet leaving a lot of questions unanswered. Many of us in the nephrology field were awaiting the JNC 8 for years.
So as you can imagine when the JNC 8 came along, just released on December 18, I was anticipating a lot of questions being resolved.  As a nephrology fellow I was looking forward to more specific guidelines and recommendations: what should I do with my elderly hypertensives, my patients with proteinuric CKD?  How about my hemodialysis patients?  Finally, I would get some insightful, specific recommendations on these special populations, or so I thought.
What I did get was a list of 9 recommendations, 9 generic recommendations that do not address my concerns as a budding nephrologist.  In patients over 60 years of age, target a BP of <150/90 mmHg.  However, if they are able to achieve a systolic BP <140 mmHg without adverse effects, than that is fine too.  A goal of <140/90mmHg should be targeted in patients under 60.  If one is over 18 years old and has CKD or diabetes, once again target <140/90mmHg.  An angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) should be used here.   In the black population, those with or without diabetes, a thiazide type diuretic or calcium channel blocker is the preferred initial agent of choice.  In the non black population, a thiazide type diuretic, calcium channel blocker, ACEI, or ARB, can be used. 
While nephrology specific questions were not addressed in detail, these guidelines do serve as the blueprint to help treat those with essential hypertension.  They are a framework for all clinicians to follow to help with all patient types.   They should be succinct, straightforward treatment recommendations that can be quickly applied in the clinic.
 That is exactly what these new guidelines are.  This is very useful information that will benefit many patients.  Tolerating higher blood pressures in elderly patients and avoiding some of the adverse effects of the medications is surely a good thing.  This will help a lot of clinicians realize that attaining a goal blood pressure is oftentimes more important than how it is achieved.  Ultimately, patients and physicians will see positive results.    

The AAFP gives a summary of the guidelines. Also check out the review on BMJ blog on JNC 8

Louis Spiegel, MD
Renal Fellow in training

Monday, December 2, 2013

IN THE NEWS: New guidelines for Hypertension in Pregnancy

A recent task force from ACOG ( included high risk OB, anesthesiologists, nephrologists) in 2013 re-evaluated the definition and concept of using proteinuria in the diagnosis of pre-eclampsia. Proteinuria is not going to be considered a hard finding anymore for the diagnosis of pre-eclampsia. The ACOG felt that this would delay diagnosis in many cases. The entire report is found here.
Proteinuria seemed to have been down graded in many instances in the report. 

Diagnosis:

BP criteria remained
Proteinuria over 5gm has been eliminated from the term of severe preclampsia.
Severe features of pre-eclampsia now include: BP changes, SBP>160mmHg, low platelets, impaired liver function, AKI, pul edema and new onset cerebral disturbances.

Some other changes:

  • Screening to predict preeclampsia beyond taking an appropriate medical history to evaluate for risk factors is not recommended.
  • Vitamin C or vitamin E to prevent preeclampsia is not recommended.
  • Daily low-dose aspirin to help prevent preeclampsia is suggested in very high-risk women with a history of preeclampsia and preterm delivery.
  • Antihypertensive medication is recommended for severe hypertension during pregnancy.
  • A decision to deliver should not be based on the amount of proteinuria or change in the amount of proteinuria.
  • The use of magnesium sulfate is recommended for severe preeclampsia, eclampsia, or HELLP syndrome.

Risk factors the task force came up with for pre-eclampsia:

Primiparity
Prior pre eclampsia
CKD
Chronic HTN
Thrombophilia history
Multi-fetal pregnancy
IVF
Family history
DM I or II
Obesity
SLE
Advanced maternal age ( >40)

Wednesday, May 9, 2012

IN THE NEWS:ACR Lupus Nephritis Guidelines

Expert panel published recently the first ever guide to Lupus Nephritis treatment. The medical news community and lay press has mentioned it at numerous occasions already
Some summary points after looking at it

1. Definition of Lupus Nephritis included the usual persistent proteinuria, active sediment but noted that if a kidney biopsy showed immune complex mediated GN compatible with lupus nephritis would also qualify for the diagnosis. Finally, an opinion of the nephrologist or rheumatologist was good as well.
2. The panel recommended that all with active lupus nephritis, previously untreated undergo a renal biopsy but evidence for this was LEVEL C.
3. Treatment of disease be based on the class of lupus identified on biopsy.
4. Class I and II- conservative management and no active treatment ( Level C evidence)
5. Class III, IV and V- require treatment
6. Class III and IV- MMF induction or IV CYC along with steroids ( Level A evidence based on ALMS trial)
7. Myfortic was mentioned by the expert panel as equivalent to MMF in inducing lupus nephritis
8. Euro Lupus ( 500mg of IV CYC every 2 weeks) for total of 6 doses be used for Caucasians and patients of European origin and the NIH protocol( 500-1000mg/m2 IV once a month for 6 doses) be used for the rest.
9. Pulse IV steroids for 3 doses and then 0.5mg-1mg/kg daily dosing is needed( level C evidence)
10. Induction for Class IV/V with crescents included steroids but no recommendations made strongly regarding use of IV CYC or MMF for this group.  Both are mentioned.
11. Pure Class V:- MMF with steroids ( PO only) ( level A evidence)
12. AZA or MMF can be used for maintenance therapy ( level A evidence)

Some of the other things the task force discusses is changing regimen when initial treatment fails, pregnancy related to SLE treatment options and monitoring of lupus nephritis.

Take a look at the original article 
Take a look at a critical review by the Kidney Doctor Blog.


Tuesday, January 26, 2010

Clinical Transplantation: KDIGO Transplant Guidelines

The Feb 2010 issue of Kidney International has summarized the KDIGO clinical practice guidelines for kidney transplant recipients. Its a very brief and to the point summary to standardize transplant care all around the globe. Things we always talked about as transplant physicians and wondered were all discussed and laid down as what should be done and what is the grade of evidence behind it.
For induction, for instance, they recommend( Grade 1B) that an IL2 -RA be used as first line agent and antilymphocyte depleting agent to be used for all kidney transplant with immunologic risk( Grade 2B)
Also, interesting to note that there is Grade2B evidence and they suggest that in patients who are at low immunological risk and who receive induction therapy, corticosteroids could be discontinued during the first week after transplantation. Other concepts on BK treatment, Bone disease, CMV, Cancer and rejection. All are discussed. I think its a good start and an essential read for all of us.

All Posts

Search This Blog